Literature DB >> 35412010

Intraclass correlation coefficients for weight loss cluster randomized trials in primary care: The PROPEL trial.

Peter T Katzmarzyk1, Kara D Denstel1, Corby K Martin1, Robert L Newton1, John W Apolzan1, Emily F Mire1, Ronald Horswell1, William D Johnson1, Andrew W Brown2, Dachuan Zhang1.   

Abstract

The aim of this study was to compute intra-class correlations (ICCs) for weight-related and patient-reported outcomes in a cluster randomized clinical trial (cRCT) for weight loss. Baseline and follow-up data from the Promoting Successful Weight Loss in Primary Care in Louisiana (PROPEL) cRCT were used in this analysis. ICCs were computed for baseline and follow-up measures, and changes in body weight, cardiometabolic risk factors and health-related and weight-related quality of life at 6, 12, 18 and 24 months. Baseline ICCs ranged from 0 for PROMIS measures of anxiety and fatigue to 0.055 for total cholesterol (median = 0.019). The ICCs were higher for changes and decreased over time during follow-up. The ICCs for changes were highest in the pooled sample (intervention and usual care combined) followed by the intervention and usual care groups, respectively. The results demonstrated significant ICCs for several outcomes in a weight loss cRCT. The ICCs differed in magnitude depending on whether baseline versus longitudinal data were used, whether data were combined across treatment arms or were considered separately, and varied across the follow-up period. All these factors must be considered when choosing an ICC to inform sample size estimates for future weight loss cRCTs conducted in primary care settings.
© 2022 World Obesity Federation.

Entities:  

Keywords:  design effect; group-randomized; obesity; power; sample size

Mesh:

Year:  2022        PMID: 35412010      PMCID: PMC9283264          DOI: 10.1111/cob.12524

Source DB:  PubMed          Journal:  Clin Obes        ISSN: 1758-8103


  23 in total

Review 1.  Patterns of intra-cluster correlation from primary care research to inform study design and analysis.

Authors:  Geoffrey Adams; Martin C Gulliford; Obioha C Ukoumunne; Sandra Eldridge; Susan Chinn; Michael J Campbell
Journal:  J Clin Epidemiol       Date:  2004-08       Impact factor: 6.437

2.  Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART).

Authors:  Donna R Parker; Evangelos Evangelou; Charles B Eaton
Journal:  Contemp Clin Trials       Date:  2005-04       Impact factor: 2.226

3.  Cluster randomised trials: time for improvement. The implications of adopting a cluster design are still largely being ignored.

Authors:  M K Campbell; J M Grimshaw
Journal:  BMJ       Date:  1998-10-31

Review 4.  The intracluster correlation coefficient in cluster randomisation.

Authors:  S M Kerry; J M Bland
Journal:  BMJ       Date:  1998-05-09

Review 5.  Best (but oft-forgotten) practices: designing, analyzing, and reporting cluster randomized controlled trials.

Authors:  Andrew W Brown; Peng Li; Michelle M Bohan Brown; Kathryn A Kaiser; Scott W Keith; J Michael Oakes; David B Allison
Journal:  Am J Clin Nutr       Date:  2015-05-27       Impact factor: 7.045

Review 6.  Essential Ingredients and Innovations in the Design and Analysis of Group-Randomized Trials.

Authors:  David M Murray; Monica Taljaard; Elizabeth L Turner; Stephanie M George
Journal:  Annu Rev Public Health       Date:  2019-12-23       Impact factor: 21.981

7.  Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-lite) in a community sample.

Authors:  Ronette L Kolotkin; Ross D Crosby
Journal:  Qual Life Res       Date:  2002-03       Impact factor: 4.147

8.  Effects of a 2-Year Primary Care Lifestyle Intervention on Cardiometabolic Risk Factors: A Cluster-Randomized Trial.

Authors:  Christoph Höchsmann; James L Dorling; Corby K Martin; Robert L Newton; John W Apolzan; Candice A Myers; Kara D Denstel; Emily F Mire; William D Johnson; Dachuan Zhang; Connie L Arnold; Terry C Davis; Vivian Fonseca; Carl J Lavie; Eboni G Price-Haywood; Peter T Katzmarzyk
Journal:  Circulation       Date:  2021-02-09       Impact factor: 29.690

Review 9.  A pragmatic view on pragmatic trials.

Authors:  Nikolaos A Patsopoulos
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

10.  Intra-cluster correlation coefficients in primary care patients with type 2 diabetes and hypertension.

Authors:  Yi Lin Lee; Yvonne Mei Fong Lim; Kian Boon Law; Sheamini Sivasampu
Journal:  Trials       Date:  2020-06-16       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.